Ventus Therapeutics

Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Ventus' structural…


Founded
2019
Headcount
51
Open roles
0
Last raised
Grant · $150K

SECTION I · THE BRIEF

Inside Ventus Therapeutics

Brief #35729Updated 18 NOV 2025WALTHAMGVGRANT
Employbl Dossier

Ventus Therapeutics

Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Ventus'…

Founded
2019
Headcount
51
Open roles
0
Last raised
Grant · $150K
Section II · Premium ProfileMembers only
  • 01Engineering interview process at Ventus TherapeuticsLocked
  • 02Tech stack & infrastructure choicesLocked
  • 03Culture & day-to-day work styleLocked
  • 04Why join now vs. 6 months from nowLocked
  • 05Hiring focus & open headcount by teamLocked
  • 06Comp philosophy and band contextLocked

7-day free trial · $25/mo · cancel anytime


LEADERSHIP

Founders & key people

Judy LiebermanJudy Lieberman
Richard FlavellRichard Flavell
Hao WuHao Wu
Dan McKayDan McKay
Thomas TuschlThomas Tuschl

OPEN ROLES

Hiring at Ventus Therapeutics

No open roles listed right now. Check back soon or search all jobs →


FUNDING

Capital raised

Total Amount Raised: $370,150,016

Ventus Therapeutics' Investors

Ventus Therapeutics Funding Rounds

  • Grant

    $150,000

  • Grant

    $150,000

    Grant Investors

    The Michael J. Fox Foundation for Parkinson's Research
  • Corporate Round

    $70,000,000

  • Corporate Round

    $70,000,000

    Corporate Round Investors

    Novo Nordisk
  • Series C

    $140,000,000

  • Series C

    $140,000,000

    Series C Investors

    RA Capital Management
    SoftBank Vision Fund
    Alexandria Venture Investments
    Qatar Investment Authority
    GV
    BVF Partners
    Casdin Capital
    Fonds de solidarité FTQ
    Cormorant Asset Management
    Versant Ventures
    Andreessen Horowitz
  • Series B

    $100,000,000

  • Series B

    $100,000,000

    Series B Investors

    RA Capital Management
    Alexandria Venture Investments
    GV
    BVF Partners
    Casdin Capital
    Versant Ventures
    Fonds de solidarité FTQ
    Cormorant Asset Management
  • Series A

    $60,000,000

  • Series A

    $60,000,000

    Series A Investors

    Versant Ventures
    GV
Funding info provided by Diffbot.

TAGS

Categorized in

Company Collections

These are collections Ventus Therapeutics is a part of. Click on the collection name to view similar companies.

Ventus Therapeutics' Investors

Ventus Therapeutics' Tech Stack


LOCATIONS

Where they work

Ventus Therapeutics Headquarters Location

100 Beaver St Suite 202, Waltham, MA, 02453

Loading map…